These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 7758805)
1. The importance of acidic amino acid residues in the binding of ligands to the V1a vasopressin receptor. Davies AR; Wheatley M Biochem Soc Trans; 1995 Feb; 23(1):85S. PubMed ID: 7758805 [No Abstract] [Full Text] [Related]
2. Synthetic rat V1a vasopressin receptor fragments interfere with vasopressin binding via specific interaction with the receptor. Mendre C; Dufour MN; Le Roux S; Seyer R; Guillou L; Calas B; Guillon G J Biol Chem; 1997 Aug; 272(34):21027-36. PubMed ID: 9261104 [TBL] [Abstract][Full Text] [Related]
3. Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor. Howl J; Wang X; Kirk CJ; Wheatley M Eur J Biochem; 1993 Apr; 213(2):711-9. PubMed ID: 8477743 [TBL] [Abstract][Full Text] [Related]
5. Mapping peptide antagonist binding sites of the human V1a and V2 vasopressin receptors. Mouillac B; Phalipou S; Cotte N; Balestre MN; Hibert M; Manning M; Barberis C Adv Exp Med Biol; 1998; 449():359-61. PubMed ID: 10026825 [No Abstract] [Full Text] [Related]
6. Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors. Rodrigo J; Pena A; Murat B; Trueba M; Durroux T; Guillon G; Rognan D Mol Endocrinol; 2007 Feb; 21(2):512-23. PubMed ID: 17082326 [TBL] [Abstract][Full Text] [Related]
7. Defining the ligand-binding site for vasopressin receptors: a peptide mimetic approach. Howl J; Parslow RA; Wheatley M Biochem Soc Trans; 1995 Feb; 23(1):103-8. PubMed ID: 7758661 [No Abstract] [Full Text] [Related]
8. Design and synthesis of heterofunctional V1a-selective vasopressin receptor ligands with lysine at position 9. Howl J; New DC; Wheatley M J Mol Endocrinol; 1992 Oct; 9(2):123-9. PubMed ID: 1418383 [TBL] [Abstract][Full Text] [Related]
9. Khusimol, a non-peptide ligand for vasopressin V1a receptors. Rao RC; Serradeil-Le Gal C; Granger I; Gleye J; Augereau JM; Bessibes C J Nat Prod; 1994 Oct; 57(10):1329-35. PubMed ID: 7807119 [TBL] [Abstract][Full Text] [Related]
10. A single residue (arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists. Hawtin SR; Wesley VJ; Parslow RA; Simms J; Miles A; McEwan K; Wheatley M Mol Endocrinol; 2002 Mar; 16(3):600-9. PubMed ID: 11875119 [TBL] [Abstract][Full Text] [Related]
11. Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes. Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G Biochem Biophys Res Commun; 1994 Feb; 199(1):353-60. PubMed ID: 8123034 [TBL] [Abstract][Full Text] [Related]
12. Characterization of an epitope-tagged vasopressin V1a receptor: a probe for receptor structure and function. Hawtin SR; Wheatley M Biochem Soc Trans; 1997 Aug; 25(3):437S. PubMed ID: 9388661 [No Abstract] [Full Text] [Related]
13. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Postina R; Kojro E; Fahrenholz F Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828 [TBL] [Abstract][Full Text] [Related]
14. Characterization of dicyclohexylcarbodiimide binding site on coupling factor 1 of mitochondrial and bacterial membrane-bound ATPases. Pougeois R; Satre M; Vignais PV FEBS Lett; 1980 Aug; 117(1):344-8. PubMed ID: 6447624 [No Abstract] [Full Text] [Related]